Under construction – not a live service
Sign in
Taking people in CzechiaNo phase

Ultrasound-guided needle biopsy to examine suspected ovarian cancer tissue

Studies a needle biopsy guided by ultrasound in adults with suspected ovarian cancer.

Plain-language title generated from the registry record
Registry title: Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.

Key facts

Where
Hradec Králové, CzechiaSee the site

Where in Czechia

  • Univeristy Hospital Hradec KraloveHradec Králové, CzechiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital Hradec Kralove
Trial code
NCT06689605
Record updated
26 March 2025
Original description
The goal of this prospective observational study is to evaluate the role of ultrasound-guided tru-cut biopsy (in the hands of an expert certified sonographer within a gynecological center)in patients with suspected ovarian cancer.Read full original descriptionShow less

Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.

The goal of this prospective observational study is to evaluate the role of ultrasound-guided tru-cut biopsy (in the hands of an expert certified sonographer within a gynecological center)in patients with suspected ovarian cancer.

The main questions it aims to answer are:

Is the material from tru-cut biopsy adequate for histopathological and immunohistochemical examination? Is the material accurate in comparison with the final pathological specimen? What are the patient experience and complications after the procedure?

Participants who will undergo a standard tru-cut biopsy procedure will need to additionally answer the questionnaire.

Inclusion: suspected advanced ovarian cancer; indication for tru-cut biopsy by multidisciplinary oncoboard.

Exclusion: patient deny to undergo tru-cut biopsy.

ClinicalTrials.gov NCT06689605